Risperidone in Children and Adolescents with Pervasive Developmental Disorder: Pilot Trial and Follow-Up

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of child and adolescent psychopharmacology

• Publication date

  1997-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1089/cap.1997.7.167PMID 9466234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

  1997cited by this paper
• Case study: risperidone-induced hepatotoxicity in pediatric patients.

  1997cited by this paper
• Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.

  1997cited by this paper
• Tics with risperidone withdrawal.

  1997cited by this paper
• Risperidone and Explosive Aggressive Autism

  1997cited by this paper
• An open clinical trial of risperidone monotherapy in young children with autistic disorder.

  1997cited by this paper
• Risperidone in adolescents with schizophrenia: an open pilot study.

  1997cited by this paper
• Use of Risperidone in Pervasive Developmental Disorders: A Case Series

  1996cited by this paper
• Risperidone in the treatment of schizophrenia.

  1994cited by this paper
• Risperidone in the Treatment of Pervasive Developmental Disorder

  1994cited by this paper
• A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

  1993cited by this paper
• Naltrexone in autistic children: behavioral symptoms and attentional learning.

  1993cited by this paper
• Clinical considerations in the use of risperidone.

  1993cited by this paper
• Pimozide in autistic children.

  1992cited by this paper
• Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.

  1989cited by this paper
• The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children

  1989cited by this paper
• Efficacy and safety of fenfluramine in autistic children.

  1988cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper
• A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design.

  1982cited by this paper

• Efficacy of Risperidone and Methylphenidate for Problem Behaviors and Core Symptoms in Autism Spectrum Disorder: A Randomized Trial

  2022cites this paper
• Psychiatric adverse drug reactions in the paediatric population

  2020cites this paper
• First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update

  2017cites this paper
• A Risk-Benefit Analysis of Antipsychotic Medication and Contingent Skin Shock for the Treatment of Destructive Behaviors

  2017cites this paper
• 8. Autism Spectrum Disorders

  2015cites this paper
• Current Trends in the Pharmacological Treatment of Autism Spectrum Disorders

  2013cites this paper
• Hepatotoxicity of Psychotropic Drugs and Drugs of Abuse

  2013cites this paper
• The efficacy of anti-psychotic medications in treating the behavior, social, and communication deficits associated with autism spectrum disorders in children and adolescents a systematic review

  2012cites this paper
• Psychotropic drug efficacy and side effects for persons with autism spectrum disorders

  2011cites this paper
• PRACTICE PARAMETER FOR THE USE OF ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN CHILDREN AND ADOLESCENTS

  2011cites this paper
• [Use of psychotropic drugs in children, adolescents and subjects with intellectual disability: a review].

  2011cites this paper
• Aggression, Tantrums, and Other Externally Driven Challenging Behaviors

  2011cites this paper
• Using functional analysis methodology to evaluate neuroleptic medication effects on positively and negatively reinforced severe problem behavior.

  2010cites this paper
• Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.

  2010cites this paper
• Medication treatment in subjects with autistic spectrum disorders

  2009cites this paper
• autistaDisturbances in Patients with Autistic Spectrum Disorders

  2009cites this paper
• Current Practice in Psychopharmacology for Children and Adolescents with Autism Spectrum Disorders.

  2009cites this paper
• Effects of risperidone on glutamate receptor subtypes in developing rat brain.

  2009cites this paper
• Pharmacologic treatment for the core deficits and associated symptoms of autism in children.

  2009influential citation
• [Risperidone use in child and adolescent psychiatric patients].

  2008cites this paper
• Autism Spectrum Disorders: Pharmacotherapy for Challenging Behaviors

  2008cites this paper
• P0262 - Risperidone and liver function tests in children and adolescents: A short term prospective study

  2008cites this paper
• Prescription de la rispridone chez l'enfant et l'adolescent

  2008cites this paper
• Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone

  2008cites this paper
• Evidence for Effectiveness of Treatments for Autism Spectrum Disorders In Children and Adolescents October 2008

  2008cites this paper
• Effects of risperidone on dopamine receptor subtypes in developing rat brain.

  2007cites this paper
• Self injurious behavior in autism: clinical aspects and treatment with risperidone

  2006cites this paper
• Reviewing the use of antipsychotic drugs in people with intellectual disability

  2006cites this paper
• Risperidone and late onset tics

  2006cites this paper
• Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.

  2006cites this paper
• Clinical Drug Monitoring in Child and Adolescent Psychiatry: Side Effects of Atypical Neuroleptics

  2006cites this paper
• Advances in Drug Treatments for Children and Adolescents with Autism and Other Pervasive Developmental Disorders

  2005cites this paper
• Risperidone in pervasive developmental disorders

  2005cites this paper
• [Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives].

  2005cites this paper
• Prescription des psychotropes en pédopsychiatrie : limites des indications officielles et perspectives thérapeutiques

  2005cites this paper
• Use of antipsychotics in children and adolescents.

  2005cites this paper
• Psychopharmacology of Autism Spectrum Disorders

  2005cites this paper
• Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders

  2005cites this paper
• Early onset schizophrenia: diagnostic dilemmas and treatment challenges

  2004cites this paper
• Weight Gain Associated with Atypical Antipsychotic Use in Children and Adolescents

  2004cites this paper
• Atypical Antipsychotic Use in a State Hospital Inpatient Adolescent Population

  2004cites this paper
• Pharmacologic treatment of autism.

  2004cites this paper
• A Comparison of Risperidone-Induced Weight Gain Across the Age Span

  2004cites this paper
• The Effect of Atypical Antipsychotic Agents on Prolactin Levels in Children and Adolescents

  2004cites this paper
• Quetiapine in Nine Youths with Autistic Disorder

  2004cites this paper
• Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental Disorders

  2004cites this paper
• Les traitements pharmacologiques de l'autisme

  2004cites this paper
• The Use of Risperidone in Adults with Asperger Syndrome

  2004cites this paper
• Pharmacotherapy of Pervasive Developmental Disorders in Children and Adolescents

  2004cites this paper
• Pharmacogenetics of antipsychotic-induced weight gain.

  2004cites this paper
• Second-Generation Antipsychotic Medications in Children and Adolescents

  2004cites this paper
• Atypical antipsychotics in the treatment of children and adolescents: clinical applications.

  2004cites this paper
• Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.

  2003cites this paper
• NEW DRUG THERAPY IN CHILD AND ADOLESCENT PSYCHIATRY ATYPICAL ANTIPSYCHOTICS

  2003cites this paper
• Annotation: The use of psychotropic medications in children: an American view.

  2003cites this paper
• Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia

  2003cites this paper
• Risperidone in children and adolescents with conduct disorder: a single-center, open-label study.

  2003cites this paper
• A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.

  2003cites this paper
• Use of Atypical Antipsychotics in Autism

  2003cites this paper
• Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

  2003cites this paper
• Risperidone in Children and Adolescents with Autistic Disorder and Aggressive Behaviour

  2002influential citation
• Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.

  2002cites this paper
• [Possibilities and limits of treatment of aggressive behavior in patients with mental retardation with risperidone].

  2002cites this paper
• Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.

  2002cites this paper
• Pediatric psychopharmacology: A review of new developments and recent research

  2002cites this paper
• A Case Series of Eight Aggressive Young Children Treated with Risperidone

  2002cites this paper
• An Open-Label Trial of Risperidone in Children with Autism

  2002cites this paper
• Recent advances in the pharmacotherapy of autism

  2002cites this paper
• A systematic review of the use of atypical antipsychotics in autism

  2002cites this paper
• Möglichkeiten und Grenzen der Behandlung aggressiven Verhaltens bei Menschen mit geistiger Behinderung mit Risperidon

  2002cites this paper
• [Evaluated treatment approaches in child and adolescent psychiatry I].

  2001cites this paper
• [Pharmacological treatment with risperidone in children with behavior disorders].

  2001cites this paper
• Risperidone Monotherapy in Preschool Children With Pervasive Developmental Disorders

  2001cites this paper
• Pharmacotherapeutic management of autism

  2001cites this paper
• Open trial of risperidone in 24 young children with pervasive developmental disorders.

  2001cites this paper
• Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

  2001cites this paper
• Tolerability Profile of Atypical Antipsychotics in Children and Adolescents

  2001cites this paper
• Treatment of the special patient with schizophrenia

  2001cites this paper
• A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.

  2001cites this paper
• Open-Label Treatment with Risperidone of 26 Psychiatrically-Hospitalized Children and Adolescents with Mixed Diagnoses and Aggressive Behavior

  2000cites this paper
• Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

  2000cites this paper
• Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

  2000cites this paper
• The Pharmacotherapy of Target Symptoms Associated with Autistic Disorder and Other Pervasive Developmental Disorders

  2000cites this paper
• Risperidone in treating behavioural disturbances of Prader‐Willi syndrome

  2000cites this paper
• Risperidone-Associated Weight Gain in Children and Adolescents: A Retrospective Chart Review

  2000cites this paper
• Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network

  2000cites this paper
• Pharmacotherapy for Hyperactivity in Children with Autism and Other Pervasive Developmental Disorders

  2000influential citation
• Pervasive developmental disorders: a 10-year review.

  2000cites this paper
• Long-Term Risperidone for Pervasive Developmental Disorder: Efficacy, Tolerability, and Discontinuation

  2000influential citation
• Inpatient Treatment of Severe Disruptive Behaviour Disorders with Risperidone and Milieu Therapy

  2000cites this paper
• Paediatric uses of atypical antipsychotics

  2000cites this paper
• [Psychopharmacological therapy of self-injurious behavior in mentally retarded individuals].

  1999cites this paper
• The Future of Research and Practice in Behavioral Disorders: Psychopharmacology and Its School Implications

  1999cites this paper
• Hypo- and Hypersalivation Induced by Psychoactive Drugs

  1999cites this paper
• Psychopharmakotherapie des selbstverletzenden Verhaltens bei Menschen mit geistiger Behinderung

  1999cites this paper
• Indications des traitements psychotropes chez l'enfant

  1999cites this paper
• Psychopharmacology in School-Based Mental Health Services.

  1999cites this paper
• Novel antipsychotic medications in the treatment of children and adolescents.

  1999cites this paper
• Antipsychotics in children and adolescents.

  1999cites this paper
• Atypical antipsychotics in persons with developmental disabilities

  1999cites this paper